Arcticzymes Technologies ASA
F:B4V

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
F:B4V
Watchlist
Price: 1.935 EUR 1.31% Market Closed
Market Cap: €98.8m

Net Margin

7.4%
Current
Declining
by 3.9%
vs 3-y average of 11.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.4%
=
Net Income
kr7.7m
/
Revenue
kr103.1m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.4%
=
Net Income
€7.7m
/
Revenue
kr103.1m

Peer Comparison

Country Company Market Cap Net
Margin
NO
Arcticzymes Technologies ASA
OSE:AZT
1.2B NOK
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
394.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.6B USD
Loading...

Market Distribution

Higher than 71% of companies in Norway
Percentile
71th
Based on 970 companies
71th percentile
7.4%
Low
-4 257 300% — -4.2%
Typical Range
-4.2% — 6.7%
High
6.7% — 82 378.7%
Distribution Statistics
Norway
Min -4 257 300%
30th Percentile -4.2%
Median 0.8%
70th Percentile 6.7%
Max 82 378.7%

Arcticzymes Technologies ASA
Glance View

Market Cap
98.8m EUR
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

B4V Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.4%
=
Net Income
kr7.7m
/
Revenue
kr103.1m
What is Arcticzymes Technologies ASA's current Net Margin?

The current Net Margin for Arcticzymes Technologies ASA is 7.4%, which is below its 3-year median of 11.3%.

How has Net Margin changed over time?

Over the last 3 years, Arcticzymes Technologies ASA’s Net Margin has decreased from 31.8% to 7.4%. During this period, it reached a low of 2.2% on Mar 31, 2025 and a high of 31.8% on Sep 30, 2022.

Back to Top